de Saussure P, Yerly S, Tullen E, Perrin L H
Central Laboratory of Virology, Geneva University Hospital, Switzerland.
Transfusion. 1993 Feb;33(2):164-7. doi: 10.1046/j.1537-2995.1993.33293158051.x.
A blood donation from a 46-year-old homosexual man was discarded because of elevated alanine aminotransferase levels. Thirteen days later, the patient presented with symptomatic primary human immunodeficiency virus type 1 (HIV-1) infection. Virologic investigations were performed retrospectively on blood samples (including the donated blood) obtained before the symptoms. The HIV-1 genome was present, either integrated in mononuclear cell DNA or circulating in plasma, 39 days before the appearance of p24 antigen and 65 days before the appearance of HIV-1 or HIV type 2 antibody. It is concluded that p24 antigenemia is present during only a fraction of the seronegative "window" period. This case illustrates the risk of infection associated with blood transfusion in spite of HIV-1 antibody testing and stresses the need to improve nontechnical exclusion procedures as well as non-antibody-based diagnostic tests.
一名46岁同性恋男子的献血因丙氨酸转氨酶水平升高而被废弃。13天后,该患者出现有症状的1型原发性人类免疫缺陷病毒(HIV-1)感染。对症状出现前采集的血样(包括所献血液)进行了回顾性病毒学调查。在p24抗原出现前39天以及HIV-1或2型抗体出现前65天,HIV-1基因组就已存在,要么整合在单核细胞DNA中,要么在血浆中循环。结论是,p24抗原血症仅在血清阴性“窗口期”的一部分时间出现。该病例说明了尽管进行了HIV-1抗体检测,但输血仍存在感染风险,并强调需要改进非技术排除程序以及非基于抗体的诊断测试。